Presentation Summary : Statins have great untapped potential in many disease states. This potential should be looked at closely but also skeptically. Beneficial for drug companies to add as ...
Source : http://www.segageriatrics.com/wp/wp-content/uploads/2011/11/To-Cholesterol-and-Beyond2.ppt
Presentation Summary : Title: Statin Talk Author: User Last modified by: FDA.CDER Created Date: 2/13/2001 5:58:47 PM Document presentation format: On-screen Show Company
Source : http://www.fda.gov/ohrms/dockets/ac/05/slides/2005-4086OPH2_04_Edison.ppt
Presentation Summary : Why Statins? Polly Rimtepathip Pharm.D. Candidate October 28, 2011 Preceptor: Dr. Rahimi, Ali R. Methods Study design 2-year, double-blind, placebo-controlled trial ...
Source : http://www.segageriatrics.com/wp/wp-content/uploads/2011/10/Why-Statins.ppt
Presentation Summary : A Prospective, Randomized Trial of Statins Prior to Stent Implantation in Patients with Stable Angina Josef VESELKA CardioVascular Center University Hospital Motol
Source : http://www.clinicaltrialresults.org/Slides/Veselka%20STATINS_PRE-PCI_final.ppt
Presentation Summary : Statins In COPD: A Systematic Review Surinder J, Kirly P et al. Chest 2009; 136: 734-743. Divya Bappanad March 11, 2010 Journal Club Background COPD is a systemic ...
Source : http://dukeglobalhealth.org/files/Statins_In_COPD.ppt
Presentation Summary : Dupuytren’s Contracture ... (The differential diagnosis also might include metabolic and inflammatory myopathies (especially in patients taking statins), ...
Source : http://catstcmnotes.com/downloads/Biomedical%20Treatment%20of%20Disease/BiomedTx3/2-Dupuytrens%20Contracture.ppt
Presentation Summary : Hospice Medical Director ... lowering therapy Anti-platelet agents Anti-coagulants Dementia medications Osteoporosis medications Discontinuing statins What is risk of ...
Source : http://www.pahomecare.org/_files/live/Advanced_System_Management-Discontinuing_Medications_at_End-of-Life--Good___Mihalyo.ppt
Presentation Summary : ... side effects and potential drug-drug interactions * Slides ... the average patient stopped two different statins due to side effects Among current users, ...
Source : http://www.statinusage.com/Documents/usage-presentation.ppt
Presentation Summary : JUPITER AHA November 9, 2008 A Randomized Trial of Rosuvastatin in the Prevention of Cardiovascular Events Among 17,802 Apparently Healthy Men and Women With Elevated ...
Source : http://clintrialresults.org/Slides/JUPITER.ppt
Presentation Summary : Title: Statins and Cancer Author: Adam Polis Last modified by: Adam Polis Created Date: 5/13/2011 6:00:35 PM Document presentation format: On-screen Show
Source : http://www.niss.org/sites/default/files/Polis--Ezetimibe%20and%20Cancer--NISS%20June%202011.ppt
Presentation Summary : The Benefit of Statin Therapy Before and After Coronary Revascularization C. Michael Gibson, MS, MD Beth Israel Deaconess Medical Center Boston, MA
Source : http://clintrialresults.org/Slides/Gibson%20-%20pre%20pci%20statin%20therapy%20short.ppt
Presentation Summary : ... ie statins Encourage healthy lifestyle Understand that questions and concerns remain “Now this is not the end. It is not even the beginning of the end.
Source : http://metrohealth.net/wp-content/uploads/2012/01/Kovack-The-New-Lipid-Guidelines.ppt
Presentation Summary : Ezetimibe in combination therapy with statins produces slightly higher levels of liver transaminase levels than with statin therapy alone, ...
Source : https://www.lipid.org/sites/default/files/non-statin_safety.pptx
Presentation Summary : Title: Model-Based Drug Development road-map to a more efficient drug development Author: Jaap Mandema Last modified by: phanm Created Date: 10/18/2000 8:59:58 PM
Source : http://www.fda.gov/ohrms/dockets/ac/06/slides/2006-4248s2-2-QuantitativeSolutionsMandema.ppt